# Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
Canonical URL: https://biopharmsignal.com/news/STIM/neuronetics-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call
Ticker: STIM
Company: Neuronetics
Source: Neuronetics
Published: 2026-04-21 12:30 EST
Original Source URL: https://ir.neuronetics.com
## Summary

MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar®

## Article Body
MALVERN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar®
## Recent Company News
- 2026-06-02 20:30 EST — [Neuronetics Appoints Robert Greene as Senior Vice President Sales](https://biopharmsignal.com/news/STIM/neuronetics-appoints-robert-greene-as-senior-vice-president-sales) — Source: Neuronetics
- 2026-06-02 12:32 EST — [Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026](https://biopharmsignal.com/news/STIM/neuronetics-highlights-continued-advancements-in-tms-research-at-ctmss-2026) — Source: Neuronetics
- 2026-05-14 12:32 EST — [Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment](https://biopharmsignal.com/news/STIM/neuronetics-and-ant-neuro-announce-strategic-collaboration-to-integrate-neuronavigation-with-neurostar-tms-treatment) — Source: Neuronetics
- 2026-05-05 11:50 EST — [Neuronetics Reports First Quarter 2026 Financial and Operating Results](https://biopharmsignal.com/news/STIM/neuronetics-reports-first-quarter-2026-financial-and-operating-results) — Source: Neuronetics
- 2026-04-29 20:30 EST — [Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/STIM/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4) — Source: Neuronetics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)